Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00233129 · ClinicalTrials.gov registry record · NA

Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program

A NA study of Traumatic Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai.

Completed
Registry status
NA
Development phase
77
Enrollment target
1
Study location

NCT00233129: Completed NA study of Traumatic Brain Injury, sponsored by Icahn School of Medicine at Mount Sinai.

NCT00233129 is a NA study of Traumatic Brain Injury that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 77 participants, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (72% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00233129, a NA study of Traumatic Brain Injury, has completed, sponsored by Icahn School of Medicine at Mount Sinai.

COMPLETED
Registry status
NA
Development phase
77 participants
Enrollment target
1
Study location

Study Summary

This is a randomized clinical trial which compares a standard day treatment program for individuals with TBI with the "Executive Plus" program; the latter emphasizes training of attention, emotional self-regulation and problem solving. The goal of the Executive Plus program is to maximize executive functioning, as well as the long-term outcomes of community participation and satisfaction with daily life.

Conditions Studied

Interventions

  • BEHAVIORAL Top Down
  • OTHER cognitive rehabilitation day treatment program

Study Locations (1)

New York

  • Icahn School of Medicine at Mount Sinai - New York

Trial Details

FieldValue
Enrollment Target 77 participants
Start Date 2005-10
Est. Completion 2010-11
Phase NA

What the finished NCT00233129 record still lists

NCT00233129 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 77 participants, a relatively small participant target, below the 277-participant average among 171 other Traumatic Brain Injury trials with a reported enrollment target (72% lower).

The record links to 1 condition, with Traumatic Brain Injury appearing as the primary indexed condition, and to 2 interventions - of which Top Down is the first listed.

NCT00233129 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00233129 about?

NCT00233129 is a clinical study titled "Improving Executive Functions After Traumatic Brain Injury (TBI): A Clinical Trial of the "Executive Plus" Program". This is a randomized clinical trial which compares a standard day treatment program for individuals with TBI with the "Executive Plus" program; the latter emphasizes training of attention, emotional self-regulation and problem solving. The goal of the Executive Plus program is to maximize executive ...

What is the current status of trial NCT00233129?

This trial is currently completed. It is a NA study. The enrollment target is 77 participants. The study started on 2005-10. Estimated completion is 2010-11.

What conditions does trial NCT00233129 study?

This clinical trial studies the following conditions: Traumatic Brain Injury.

What interventions are being tested in trial NCT00233129?

The interventions under investigation include: Top Down (BEHAVIORAL), cognitive rehabilitation day treatment program (OTHER).

Who is sponsoring clinical trial NCT00233129?

This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00233129 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Traumatic Brain Injury

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00233129's enrollment target sits among peer trials

77 89th of 171 higher than 82 of 171 other Traumatic Brain Injury trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Traumatic Brain Injury trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02127398 · 77 participants · Phase 2

    Stool Transplants to Treat Refractory Clostridium Difficile Colitis

  • NCT04159103 · 77 participants · Phase 1

    Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

  • NCT04683003 · 77 participants · Phase 3

    A Study of TAK-755 in Participants With Congenital Thrombotic Thrombocytopenic Purpura

  • NCT05004116 · 77 participants · Phase 1

    A Study of Repotrectinib in Combination With Chemotherapy in Children and Young Adults With Solid Tumor Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00233129, the US trial registry maintained by the National Library of Medicine. NCT00233129 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.